Molecular Partners AG(MOLN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MOLN Molecular Partners AG

盘前交易 09-30 07:41:02 EDT

3.90

+0.04

+1.04%

最高3.90	最低3.75	成交量669.00
今开3.88	昨收3.86	日振幅4.00%
总市值1.49亿	流通市值8,078万	总股本3,831万
成交额2,602	换手率0.00%	流通股本2,071万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MOLN","market":"US","secType":"STK","nameCN":"Molecular Partners AG","latestPrice":3.9,"timestamp":1790712000000,"preClose":3.86,"halted":0,"volume":669,"delay":0,"changeRate":0.010362694300518144,"floatShares":20712399,"shares":38305200,"eps":-1.677647,"marketStatus":"盘前交易","change":0.04,"latestTime":"09-30 07:41:02 EDT","open":3.88,"high":3.9044,"low":3.75,"amount":2602,"amplitude":0.04,"askPrice":4.12,"askSize":100,"bidPrice":3.87,"bidSize":540,"shortable":3,"etf":0,"ttmEps":-1.677647,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790775000000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1623816000000,"exchange":"NASDAQ","adjPreClose":3.9,"postHourTrading":{"tag":"盘后","latestPrice":3.9,"preClose":3.9,"latestTime":"16:10 EDT","volume":8,"amount":32.64,"timestamp":1790712608948,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9283931604318335},"requestUrl":"/m/hq/s/MOLN","defaultTab":"news","newsList":[{"id":"2518634222","title":"Molecular Partners Ag盘中异动 大幅下挫6.39%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518634222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518634222?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613465,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Molecular Partners Ag股票出现异动，股价急速下挫6.39%。截至发稿，该股报4.69美元/股，成交量201股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体跌幅为0.59%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310596403594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310596403594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MOLN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137138481","title":"Molecular Partners 年度每股亏损从上年的$(2.13)减少至$(1.81)，销售额从上年的$7.89M减少至$5.65M","url":"https://stock-news.laohu8.com/highlight/detail?id=1137138481","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137138481?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:46","pubTimestamp":1741297619,"startTime":"0","endTime":"0","summary":"Molecular Partners报告本季度每股亏损为$。公司本季度报告的销售额为$5.65百万。与去年同期的销售额$7.89百万相比，减少了28.46%。以上内容来自Benzinga Earnings专栏，原文如下：Molecular Partners  reported quarterly losses of $ per share. This is a 15.1 percent increase over losses of $ per share from the same period last year.  The company reported $5.65 million in sales this quarter. This is a 28.46 percent decrease over sales of $7.89 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Molecular Partners 年度每股亏损从上年的$(2.13)减少至$(1.81)，销售额从上年的$7.89M减少至$5.65M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MOLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517165916","title":"Molecular Partners Ag盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517165916?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271474,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Molecular Partners Ag股票出现异动，股价快速下跌5.10%。Molecular Partners Ag股票所在的生物技术行业中，整体跌幅为0.63%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223114a2628f6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223114a2628f6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517946674","title":"Molecular Partners Ag盘中异动 股价大涨6.20%报4.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517946674?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:28","pubTimestamp":1741188537,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时28分，Molecular Partners Ag股票出现异动，股价快速上涨6.20%。截至发稿，该股报4.97美元/股，成交量858股，换手率0.00%，振幅5.98%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为1.35%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305232857989d543e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305232857989d543e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","MOLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516367760","title":"Molecular Partners Ag盘中异动 大幅下跌6.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516367760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516367760?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098750,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Molecular Partners Ag股票出现波动，股价急速跳水6.96%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.25%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223230a25f04c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223230a25f04c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MOLN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514373370","title":"Molecular Partners Ag盘中异动 早盘大幅下挫5.15%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514373370?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:55","pubTimestamp":1740754528,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时55分，Molecular Partners Ag股票出现波动，股价急速跳水5.15%。截至发稿，该股报4.60美元/股，成交量275股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.24%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225528abe0f0f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225528abe0f0f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720668","title":"Molecular Partners Ag盘中异动 早盘大幅上涨5.96%报4.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720668?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409333,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分，Molecular Partners Ag股票出现异动，股价急速上涨5.96%。截至发稿，该股报4.96美元/股，成交量501股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.24%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230213962ea08f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230213962ea08f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MOLN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511613229","title":"Molecular Partners Ag盘中异动 股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511613229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511613229?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:55","pubTimestamp":1739555736,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时55分，Molecular Partners Ag股票出现异动，股价急速拉升5.49%。Molecular Partners Ag股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Moleculin Biotech, Inc.、Allogene Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2909.83%、765.60%、600.13%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为74.35%、71.65%、66.45%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015536962349f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015536962349f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MOLN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505771512","title":"Molecular Partners Ag盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505771512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505771512?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:17","pubTimestamp":1737472629,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时17分，Molecular Partners Ag股票出现异动，股价大幅下挫5.31%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为1.23%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121231709a22a61be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121231709a22a61be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504601381","title":"Molecular Partners Ag盘中异动 股价大跌6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504601381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504601381?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:03","pubTimestamp":1737126225,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时03分，Molecular Partners Ag股票出现异动，股价大幅下挫6.20%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.59%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230345986a1dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230345986a1dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503913670","title":"Molecular Partners Ag盘中异动 股价大跌5.88%报5.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503913670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503913670?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:30","pubTimestamp":1737037843,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时30分，Molecular Partners Ag股票出现波动，股价大幅下跌5.88%。截至发稿，该股报5.44美元/股，成交量1810股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.00%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501162230439606078f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501162230439606078f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503627071","title":"Molecular Partners Ag盘中异动 大幅上涨7.28%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503627071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503627071?lang=zh_cn&edition=full","pubTime":"2025-01-16 01:20","pubTimestamp":1736961629,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日01时20分，Molecular Partners Ag股票出现波动，股价急速拉升7.28%。截至发稿，该股报5.75美元/股，成交量8974股，换手率0.02%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.96%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116012029a22326dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116012029a22326dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MOLN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503585887","title":"Molecular Partners Ag盘中异动 早盘股价大涨7.05%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503585887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503585887?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778779,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Molecular Partners Ag股票出现异动，股价急速拉升7.05%。截至发稿，该股报5.34美元/股，成交量2497股，换手率0.01%，振幅3.31%。Molecular Partners Ag股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2839.31%、1928.34%、390.86%，振幅较大的相关个股有Champions Oncology, Inc.、Abivax、Salarius Pharmaceuticals, Inc.，振幅分别为102.87%、100.00%、84.34%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223259aba9311b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223259aba9311b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","MOLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502386237","title":"Molecular Partners Ag盘中异动 股价大跌7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502386237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502386237?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:31","pubTimestamp":1736519481,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时31分，Molecular Partners Ag股票出现波动，股价大幅下挫7.10%。Molecular Partners Ag股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为893.06%、130.70%、101.22%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Mbx Biosciences, Inc.、Fractyl Health, Inc.，振幅分别为6.78%、5.75%、5.72%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223121aba6024e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223121aba6024e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","MOLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501229739","title":"Molecular Partners Ag盘中异动 下午盘快速拉升6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501229739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501229739?lang=zh_cn&edition=full","pubTime":"2025-01-08 03:27","pubTimestamp":1736278048,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日03时27分，Molecular Partners Ag股票出现异动，股价急速上涨6.03%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为1.32%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010803272895fbcf19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010803272895fbcf19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501262898","title":"Molecular Partners Ag盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501262898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501262898?lang=zh_cn&edition=full","pubTime":"2025-01-07 04:30","pubTimestamp":1736195432,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日04时30分，Molecular Partners Ag股票出现波动，股价大幅拉升5.34%。截至发稿，该股报5.13美元/股，成交量3125股，换手率0.01%，振幅1.37%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.33%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107043033aba0d3bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107043033aba0d3bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MOLN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500110907","title":"Molecular Partners Ag盘中异动 早盘股价大涨5.03%报5.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500110907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500110907?lang=zh_cn&edition=full","pubTime":"2025-01-03 23:14","pubTimestamp":1735917268,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日23时14分，Molecular Partners Ag股票出现异动，股价大幅上涨5.03%。截至发稿，该股报5.12美元/股，成交量13股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.40%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103231428a214725d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103231428a214725d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500241927","title":"Molecular Partners Ag盘中异动 急速上涨5.10%报4.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500241927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500241927?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:41","pubTimestamp":1735828864,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时41分，Molecular Partners Ag股票出现波动，股价急速上涨5.10%。截至发稿，该股报4.99美元/股，成交量139股，换手率0.00%，振幅0.00%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.70%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102224104a2130344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102224104a2130344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","MOLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495521863","title":"Molecular Partners Ag盘中异动 快速跳水7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495521863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495521863?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:28","pubTimestamp":1735572481,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时28分，Molecular Partners Ag股票出现波动，股价快速跳水7.74%。Molecular Partners Ag股票所在的生物技术行业中，整体跌幅为1.09%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230232801a20f38e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230232801a20f38e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MOLN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493761307","title":"Molecular Partners Ag盘中异动 股价大涨7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493761307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493761307?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:58","pubTimestamp":1734965933,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时58分，Molecular Partners Ag股票出现异动，股价大幅拉升7.09%。Molecular Partners Ag股票所在的生物技术行业中，整体涨幅为0.04%。Molecular Partners Ag公司简介：Molecular Partners AG 是一家临床阶段的生物制药公司。该公司开发了一种名为 DARPin 疗法的蛋白质疗法，用于治疗包括癌症和威胁视力的疾病在内的重疾。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223225853a2051716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223225853a2051716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MOLN","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.molecularpartners.com","stockEarnings":[{"period":"1week","weight":-0.0845},{"period":"1month","weight":-0.1333},{"period":"3month","weight":-0.0076},{"period":"6month","weight":0.013},{"period":"1year","weight":0.0598},{"period":"ytd","weight":-0.1052}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":-0.0067},{"period":"3month","weight":0.0247},{"period":"6month","weight":0.1652},{"period":"1year","weight":0.1515},{"period":"ytd","weight":0.1207}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Molecular Partners AG于2004年11月22日在瑞士注册成立。该公司是一家临床阶段的生物制药公司，将其开创性的DARPin候选产品应用于治疗严重疾病，目前的重点是传染病、肿瘤学和眼科。该公司的DARPin平台是使用锚蛋白重复蛋白设计的，允许该公司构建具有多种作用机制的候选产品，以解决复杂的生物学问题，同时可能为患者提供更高疗效和更少不良事件的产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.123225},{"month":2,"riseRate":0.2,"avgChangeRate":-0.018367},{"month":3,"riseRate":0,"avgChangeRate":-0.128928},{"month":4,"riseRate":0.6,"avgChangeRate":-0.109141},{"month":5,"riseRate":0,"avgChangeRate":-0.031824},{"month":6,"riseRate":0.4,"avgChangeRate":0.153556},{"month":7,"riseRate":0.5,"avgChangeRate":0.015158},{"month":8,"riseRate":0.5,"avgChangeRate":-0.038296},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.079808},{"month":10,"riseRate":0.2,"avgChangeRate":-0.0468},{"month":11,"riseRate":0.8,"avgChangeRate":0.037997},{"month":12,"riseRate":0.6,"avgChangeRate":0.052197}],"exchange":"NASDAQ","name":"Molecular Partners AG","nameEN":"Molecular Partners AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Molecular Partners AG(MOLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Molecular Partners AG(MOLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Molecular Partners AG,MOLN,Molecular Partners AG股票,Molecular Partners AG股票老虎,Molecular Partners AG股票老虎国际,Molecular Partners AG行情,Molecular Partners AG股票行情,Molecular Partners AG股价,Molecular Partners AG股市,Molecular Partners AG股票价格,Molecular Partners AG股票交易,Molecular Partners AG股票购买,Molecular Partners AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Molecular Partners AG(MOLN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Molecular Partners AG(MOLN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}